Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort

Michael D. Miedema; Faye L. Lopez; Michael J. Blaha; Salim S. Virani; Josef Coresh; Christie M. Ballantyne; Aaron R. Folsom

doi:10.1001/jamainternmed.2014.6288

Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort

Michael D. Miedema, Faye L. Lopez, Michael J. Blaha, Salim S. Virani, Josef Coresh, Christie M. Ballantyne, Aaron R. Folsom

Epidemiology

Research output: Contribution to journal › Letter › peer-review

22 Scopus citations

Original language	English (US)
Pages (from-to)	138-140
Number of pages	3
Journal	JAMA internal medicine
Volume	175
Issue number	1
DOIs	https://doi.org/10.1001/jamainternmed.2014.6288
State	Published - Jan 1 2015

Access

10.1001/jamainternmed.2014.6288

OpenUrl availability

Full text

Cite this

Miedema, M. D., Lopez, F. L., Blaha, M. J., Virani, S. S., Coresh, J., Ballantyne, C. M., & Folsom, A. R. (2015). Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort. JAMA internal medicine, 175(1), 138-140. https://doi.org/10.1001/jamainternmed.2014.6288

Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort. / Miedema, Michael D.; Lopez, Faye L.; Blaha, Michael J. et al.
In: JAMA internal medicine, Vol. 175, No. 1, 01.01.2015, p. 138-140.

Research output: Contribution to journal › Letter › peer-review

Miedema, MD, Lopez, FL, Blaha, MJ, Virani, SS, Coresh, J, Ballantyne, CM & Folsom, AR 2015, 'Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort', JAMA internal medicine, vol. 175, no. 1, pp. 138-140. https://doi.org/10.1001/jamainternmed.2014.6288

@article{aff93fcfcca94e33a4e1d4e00707da25,

title = "Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort",

author = "Miedema, {Michael D.} and Lopez, {Faye L.} and Blaha, {Michael J.} and Virani, {Salim S.} and Josef Coresh and Ballantyne, {Christie M.} and Folsom, {Aaron R.}",

year = "2015",

month = jan,

day = "1",

doi = "10.1001/jamainternmed.2014.6288",

language = "English (US)",

volume = "175",

pages = "138--140",

journal = "JAMA internal medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort

T2 - The atherosclerosis risk in communities study cohort

AU - Miedema, Michael D.

AU - Lopez, Faye L.

AU - Blaha, Michael J.

AU - Virani, Salim S.

AU - Coresh, Josef

AU - Ballantyne, Christie M.

AU - Folsom, Aaron R.

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84920593746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920593746&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2014.6288

DO - 10.1001/jamainternmed.2014.6288

M3 - Letter

C2 - 25401375

AN - SCOPUS:84920593746

SN - 2168-6106

VL - 175

SP - 138

EP - 140

JO - JAMA internal medicine

JF - JAMA internal medicine

IS - 1

ER -

Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort

Access

OpenUrl availability

Other files and links

Cite this